AI Article Synopsis

  • GLT-1 (EAAT2) is a key glial glutamate transporter in the mammalian brain, crucial for terminating neurotransmitter signals at excitatory synapses.
  • A new splice variant of GLT-1, where exon 4 is skipped, was isolated from adult rat brain tissue through RT-PCR and encodes a 500 amino acid protein.
  • The study found that this variant's mRNA is present in various brain regions and certain tissues, and suggests it could either function as a glutamate transporter or modulate the function of other glutamate transporters.

Article Abstract

GLT-1 (EAAT2) is an abundant glial glutamate transporter in the mammalian brain. It plays important roles, especially in the termination of neurotransmitter signals at excitatory synapses in grey matter. In normal brain, alternative splicing of GLT-1 has been described, where exons in the GLT-1 gene are skipped or intronic sequences spliced in to generate new sequences. This study describes the isolation of a cDNA clone encoding a new splice variant of GLT-1 where exon 4 is skipped. This novel variant was isolated by RT-PCR cloning from adult rat brain and encodes a protein of 500 amino acids (MW ~54.5 kDa). RT-PCR analysis showed that mRNA was readily detectable in various brain regions of rat, primary astrocyte cultures and in tissues such as testis, but little mRNA was detectable in retina and liver. An antibody that selectively recognizes exon-4 skipping GLT-1 revealed strong signals in Western blots and labelled grey matter astrocytes. We conclude that exon-4 skipping GLT 1 is abundantly expressed in the brain and may represent either a functional glutamate transporter or a modulator of glutamate transporter function.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neulet.2011.09.029DOI Listing

Publication Analysis

Top Keywords

glutamate transporter
16
abundantly expressed
8
grey matter
8
mrna detectable
8
exon-4 skipping
8
glt-1
6
brain
5
exon 4-skipping
4
4-skipping glt-1
4
glt-1 form
4

Similar Publications

Identification of a Subpopulation of Astrocyte Progenitor Cells in the Neonatal Subventricular Zone: Evidence that Migration is Regulated by Glutamate Signaling.

Neurochem Res

January 2025

Departments of Pediatrics and Systems Pharmacology & Translational Therapeutics, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA, 19104-4318, USA.

In mice engineered to express enhanced green fluorescent protein (eGFP) under the control of the entire glutamate transporter 1 (GLT1) gene, eGFP is found in all 'adult' cortical astrocytes. However, when 8.3 kilobases of the human GLT1/EAAT2 promoter is used to control expression of tdTomato (tdT), tdT is only found in a subpopulation of these eGFP-expressing astrocytes.

View Article and Find Full Text PDF

Background: Astrocytes play a main role in brain energy metabolism, primarily through the metabolic cooperation with neurons. The use of [F]fluorodeoxyglucose(FDG)‐PET has become a valuable indicator of neurodegeneration in Alzheimer's disease (AD), revealing a brain hypometabolic signature, but it is sensitive to changes in astrocyte metabolism. It is postulated that the activation of the excitatory amino acid transporter 2 (EAAT2) is the main trigger of FDG‐PET uptake in astrocytes.

View Article and Find Full Text PDF

Background: Glutamate is the main excitatory neurotransmitter in the brain, acting through ionotropic and metabotropic receptors, such as the neuronal metabotropic glutamate receptor 5 (mGluR5). The radiotracer [C]ABP688 binds allosterically to the mGluR5, providing a valuable tool to understand glutamatergic function. We have previously shown that neuronal [C]ABP688 binding is influenced by astrocyte activation.

View Article and Find Full Text PDF

Background: Our laboratory has demonstrated that the NLRP3 inflammasome has a critical role in the microglial innate immune response to Alzheimer’s disease (AD)‐related peptides, triggering the release of cleaved‐caspase‐1 and IL‐1β. NLRP3 activation was found in post‐mortem tissue from individuals with AD (Heneka et al., 2013) and in transgenic models of AD (APP/PS1 mice).

View Article and Find Full Text PDF

Background: Astrocytes play a main role in brain energy metabolism, primarily through the metabolic cooperation with neurons. The use of [18F]fluorodeoxyglucose(FDG)‐PET has become a valuable indicator of neurodegeneration in Alzheimer’s disease (AD), revealing a brain hypometabolic signature, but it is sensitive to changes in astrocyte metabolism. It is postulated that the activation of the excitatory amino acid transporter 2 (EAAT2) is the main trigger of FDG‐PET uptake in astrocytes.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!